logo
Plus   Neg
Share
Email

Sanofi, Abbott To Integrate Glucose Sensing And Insulin Delivery Technologies

Sanofi (SNYNF,SNY) and Abbott have partnered to integrate glucose sensing and insulin delivery technologies that would initially enable data sharing, at the consent of the user, between Abbott's FreeStyle Libre mobile app and cloud software and Sanofi's connected insulin pens, apps and cloud software that are currently in development.

The data sharing will enable both people with diabetes and their doctors to make better informed treatment decisions around medication, nutrition and lifestyle, Sanofi said in a statement.

Sanofi said it is currently working to provide connected pens, apps and cloud software that will be compatible with the FreeStyle Libre system and its compatible digital health tools. They aim to bring this to people with diabetes within the next few years, subjects to local regulatory approvals.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Department of Transportation says it received lesser number of complaints from consumers about airline services in August. In August, DOT received 1,712 complaints about airline service from consumers, down 1.0% from the total of 1,730 filed in August 2018 and down 8.7% from the 1,875 received... Shares of Netflix Inc. (NFLX) jumped 7% in extended trading session Wednesday after the online-video streaming giant said it added more subscribers in the third quarter after a disappointing previous quarter. The company's third-quarter earnings topped Wall Street estimates, as revenues surged 31%. Netflix... Alcoa Corp. (AA), the largest producer of aluminum in the US, Wednesday posted a wider-than-expected loss for the third quarter, reflecting a drop in revenues as well as one-time charges related to two smelters in Spain. The company also announced a "portfolio review" of its smelting and refining capacity...
Follow RTT
>